A novel DAG-dependent mechanism links PKCa and Cyclin B1 regulating cell cycle progression

Through the years, different studies showed the involvement of Protein Kinase C (PKC) in cell cycle control, in particular during G1/S transition. Little is known about their role at G2/M checkpoint. In this study, using K562 human erythroleukemia cell line, we found a novel and specific mechanism through which the conventional isoform PKC⍺ positively affects Cyclin B1 modulating G2/M progression of cell cycle. Since the kinase activity of this PKC isoform was not necessary in this process, we demonstrated that PKC⍺, physically interacting with Cyclin B1, avoided its degradation and stimulated its nuclear import at mitosis. Moreover, the process resulted to be strictly connected with the increase in nuclear diacylglycerol levels (DAG) at G2/M checkpoint, due to the activity of nuclear Phospholipase C β1 (PLCβ1), the only PLC isoform mainly localized in the nucleus of K562 cells. Taken together, our findings indicated a novel DAG dependent mechanism able to regulate the G2/M progression of the cell cycle.

[1]  L. Cocco,et al.  Protein kinase C involvement in cell cycle modulation. , 2014, Biochemical Society transactions.

[2]  J. McCubrey,et al.  PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells , 2014, Oncotarget.

[3]  B. Spänkuch,et al.  Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 status , 2014, Oncotarget.

[4]  J. McCubrey,et al.  Nuclear PI-PLCβ1: an appraisal on targets and pathology. , 2014, Advances in biological regulation.

[5]  Yong Ryoul Yang,et al.  The physiological roles of primary phospholipase C. , 2013, Advances in biological regulation.

[6]  G. Melino,et al.  DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity , 2013, Oncotarget.

[7]  J. McCubrey,et al.  K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway , 2013, Cell cycle.

[8]  A. Newton,et al.  Protein kinase C pharmacology: refining the toolbox. , 2013, The Biochemical journal.

[9]  J. Black,et al.  Protein kinase C signaling and cell cycle regulation , 2013, Front. Immun..

[10]  Stephen L. Abrams,et al.  Advances in Targeting Signal Transduction Pathways , 2012, Oncotarget.

[11]  G. Viglietto,et al.  PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest , 2012, Cell cycle.

[12]  Martin Wasser,et al.  Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration , 2012, Proceedings of the National Academy of Sciences.

[13]  M. Falasca,et al.  Phosphoinositides signalling in cancer: focus on PI3K and PLC. , 2012, Advances in biological regulation.

[14]  M. Collins,et al.  Coordinating cell cycle progression via cyclin specificity , 2011, Cell cycle.

[15]  V. Gottifredi,et al.  p21 regulates the cell cycle…or the other way around? , 2011, Cell cycle.

[16]  O. Gavet,et al.  Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. , 2010, Developmental cell.

[17]  A. Newton,et al.  Protein kinase C: poised to signal. , 2010, American journal of physiology. Endocrinology and metabolism.

[18]  C. Rossé,et al.  PKC and the control of localized signal dynamics , 2010, Nature Reviews Molecular Cell Biology.

[19]  A. Bradford,et al.  Protein kinase C alpha‐dependent signaling mediates endometrial cancer cell growth and tumorigenesis , 2009, International journal of cancer.

[20]  A. Newton,et al.  Lipid activation of protein kinases This work was supported in part by National Institutes of Health GM43154. Published, JLR Papers in Press, November 24, 2008. , 2009, Journal of Lipid Research.

[21]  L. Cocco,et al.  Involvement of nuclear PLCβl in lamin B1 phosphorylation and G2/M cell cycle progression , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Hill,et al.  p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage , 2009, Cell cycle.

[23]  J. Black,et al.  Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells* , 2007, Journal of Biological Chemistry.

[24]  Frederick R. Cross,et al.  Multiple levels of cyclin specificity in cell-cycle control , 2007, Nature Reviews Molecular Cell Biology.

[25]  M. Kazanietz,et al.  Post-transcriptional Destabilization of p21cip1 by Protein Kinase C in Fibroblasts* , 2006, Journal of Biological Chemistry.

[26]  Gordon B Mills,et al.  Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Masahiro Tanaka,et al.  Synthesis of Anilino‐monoindolylmaleimides as Potent and Selective PKCβ Inhibitors. , 2005 .

[28]  Takashi Inaba,et al.  Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[29]  L. Pemberton,et al.  Karyopherins: from nuclear-transport mediators to nuclear-function regulators. , 2004, Trends in cell biology.

[30]  A. Murray,et al.  Recycling the Cell Cycle Cyclins Revisited , 2004, Cell.

[31]  A. Martelli,et al.  Nuclear protein kinase C isoforms: key players in multiple cell functions? , 2003, Histology and histopathology.

[32]  I. Weinstein,et al.  Roles of Specific Isoforms of Protein Kinase C in the Transcriptional Control of Cyclin D1 and Related Genes* , 2003, Journal of Biological Chemistry.

[33]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[34]  R. Irvine.  Nuclear lipid signalling , 2003, Nature Reviews Molecular Cell Biology.

[35]  J. Pines,et al.  Active cyclin B1–Cdk1 first appears on centrosomes in prophase , 2003, Nature Cell Biology.

[36]  Robin F Irvine,et al.  Nuclear Lipid Signaling , 2000, Science's STKE.

[37]  R. Muschel,et al.  Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin. , 2001, Neuro-oncology.

[38]  S. Rhee,et al.  Regulation of phosphoinositide-specific phospholipase C. , 2001, Annual review of biochemistry.

[39]  Catherine G. Takizawa,et al.  Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. , 2000, Current opinion in cell biology.

[40]  T. Chambers,et al.  Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways , 1999, Oncogene.

[41]  A. Hershko.  Mechanisms and regulation of the degradation of cyclin B. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  P. Parker,et al.  Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes. , 1999, The Biochemical journal.

[43]  J. Pines,et al.  Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal , 1999, Current Biology.

[44]  J. Pines,et al.  Temporal and spatial control of cyclin B1 destruction in metaphase , 1999, Nature Cell Biology.

[45]  A. Fields,et al.  A Role for Nuclear Phosphatidylinositol-specific Phospholipase C in the G2/M Phase Transition* , 1997, The Journal of Biological Chemistry.

[46]  C. D’Santos,et al.  Nuclear diacylglycerol, the cell cycle, the enzymes and a red herring (or how we came to love phosphatidylcholine). , 1997, Biochemical Society transactions.

[47]  F. Hucho,et al.  Transport of protein kinase C alpha into the nucleus requires intact cytoskeleton while the transport of a protein containing a canonical nuclear localization signal does not. , 1996, Journal of cell science.

[48]  D. Burns,et al.  Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. , 1994, The Journal of biological chemistry.

[49]  D. Burns,et al.  Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation. , 1993, The Journal of biological chemistry.

[50]  A. Martelli,et al.  Nuclear localization and signalling activity of phosphoinositidase Cβ in Swiss 3T3 cells , 1992, Nature.